We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPLK
76
DELISTED
Splunk Inc
SPLK
$38.9M 0.32%
238,200
– –
ASND icon
77
Ascendis Pharma A/S
ASND
$16.3B
$38.6M 0.32%
240,671
– –
BPMC
78
DELISTED
Blueprint Medicines
BPMC
$37.9M 0.32%
351,881
-1
-0% -$100
LOW icon
79
Lowe's Companies
LOW
$122B
$37.8M 0.31%
245,059
– –
VZ icon
80
Verizon
VZ
$202B
$37.5M 0.31%
665,001
-2
-0% -$113
ANSS
81
DELISTED
Ansys
ANSS
$36.2M 0.3%
103,664
-2
-0% -$710
KO icon
82
Coca-Cola
KO
$378B
$35.9M 0.3%
681,232
– –
PTC icon
83
PTC
PTC
$14.9B
$35.2M 0.29%
306,039
– –
PTCT icon
84
PTC Therapeutics
PTCT
$6.05B
$35.1M 0.29%
599,397
– –
XYL icon
85
Xylem
XYL
$29.6B
$34.1M 0.28%
349,115
– –
MAS icon
86
Masco
MAS
$16.5B
$33.9M 0.28%
641,829
– –
EA icon
87
Electronic Arts
EA
$52.4B
$33.6M 0.28%
243,328
+10
+0% +$1.39K
SQM icon
88
Sociedad Química y Minera de Chile
SQM
$18.8B
$33.3M 0.28%
706,800
– –
ISRG icon
89
Intuitive Surgical
ISRG
$131B
$33.3M 0.28%
127,182
– –
TECH icon
90
Bio-Techne
TECH
$11.2B
$33M 0.27%
433,132
-16
-0% -$1.46K
OLED icon
91
Universal Display
OLED
$3.85B
$32.7M 0.27%
147,987
+1
+0% +$231
LLY icon
92
Eli Lilly
LLY
$1.09T
$32.6M 0.27%
200,735
– –
BLD
93
DELISTED
TopBuild
BLD
$32.4M 0.27%
183,321
+1
+0% +$203
INTC icon
94
Intel
INTC
$437B
$32.4M 0.27%
677,394
+1
+0% +$60
ATVI
95
DELISTED
Activision Blizzard
ATVI
$32.4M 0.27%
364,536
– –
ARNA
96
DELISTED
Arena Pharmaceuticals Inc
ARNA
$31.9M 0.27%
432,049
– –
MS icon
97
Morgan Stanley
MS
$333B
$31.8M 0.26%
445,180
+2
+0% +$153
TENB icon
98
Tenable Holdings
TENB
$3.53B
$31.6M 0.26%
628,489
– –
VAR
99
DELISTED
Varian Medical Systems, Inc.
VAR
$31.4M 0.26%
186,621
– –
AMD icon
100
Advanced Micro Devices
AMD
$747B
$31.3M 0.26%
355,612
– –
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.